Allison Kempe1, Matthew F Daley2, Jennifer Pyrzanowski3, Tara Vogt4, Hai Fang5, Deborah J Rinehart6, Nicole Morgan7, Mette Riis8, Sarah Rodgers8, Emily McCormick9, Anne Hammer10, Elizabeth J Campagna11, Deidre Kile11, Miriam Dickinson12, Simon J Hambidge13, Judith C Shlay14. 1. Children's Outcomes Research Program, The Children's Hospital, Aurora, Colo; Department of Pediatrics, University of Colorado, Aurora, Colo; Colorado Health Outcomes Program, University of Colorado, Aurora, Colo. Electronic address: Allison.Kempe@childrenscolorado.org. 2. Children's Outcomes Research Program, The Children's Hospital, Aurora, Colo; Department of Pediatrics, University of Colorado, Aurora, Colo; Institute for Health Research, Kaiser Permanente, Denver, Colo. 3. Children's Outcomes Research Program, The Children's Hospital, Aurora, Colo. 4. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. 5. Department of Health System, Management and Policy, University of Colorado, Aurora, Colo. 6. Health Services Research, Denver Health, Denver, Colo. 7. Physician Billing, Denver Health, Denver, Colo. 8. Denver Public Health, Denver Health, Denver, Colo. 9. Institute for Health Research, Kaiser Permanente, Denver, Colo; Public Health Prevention Services, Centers for Disease Control and Prevention, Atlanta, Ga; Denver Public Health, Denver Health, Denver, Colo. 10. Community Health Services, Denver Health, Denver, Colo. 11. Colorado Health Outcomes Program, University of Colorado, Aurora, Colo. 12. Children's Outcomes Research Program, The Children's Hospital, Aurora, Colo; Department of Family Medicine, University of Colorado, Aurora, Colo. 13. Department of Pediatrics, University of Colorado, Aurora, Colo; Denver Public Health, Denver Health, Denver, Colo; Community Health Services, Denver Health, Denver, Colo. 14. Department of Family Medicine, University of Colorado, Aurora, Colo; Denver Public Health, Denver Health, Denver, Colo.
Abstract
OBJECTIVE: To assess rates of immunization; costs of conducting clinics; and reimbursements for a school-located influenza vaccination (SLIV) program that billed third-party payers. METHODS: SLIV clinics were conducted in 19 elementary schools in the Denver Public School district (September 2010 to February 2011). School personnel obtained parental consent, and a community vaccinator conducted clinics and performed billing. Vaccines For Children vaccine was available for eligible students. Parents were not billed for any fees. Data were collected regarding implementation costs and vaccine cost was calculated using published private sector prices. Reimbursement amounts were compared to costs. RESULTS: Overall, 30% of students (2784 of 9295) received ≥1 influenza vaccine; 39% (1079 of 2784) needed 2 doses and 80% received both. Excluding vaccine costs, implementation costs were $24.69 per vaccination. The percentage of vaccine costs reimbursed was 62% overall (82% from State Child Health Insurance Program (SCHIP), 50% from private insurance). The percentage of implementation costs reimbursed was 19% overall (23% from private, 27% from Medicaid, 29% from SCHIP and 0% among uninsured). Overall, 25% of total costs (implementation plus vaccine) were reimbursed. CONCLUSIONS: A SLIV program resulted in vaccination of nearly one third of elementary students. Reimbursement rates were limited by 1) school restrictions on charging parents fees, 2) low payments for vaccine administration from public payers and 3) high rates of denials from private insurers. Some of these problems might be reduced by provisions in the Affordable Care Act.
OBJECTIVE: To assess rates of immunization; costs of conducting clinics; and reimbursements for a school-located influenza vaccination (SLIV) program that billed third-party payers. METHODS: SLIV clinics were conducted in 19 elementary schools in the Denver Public School district (September 2010 to February 2011). School personnel obtained parental consent, and a community vaccinator conducted clinics and performed billing. Vaccines For Children vaccine was available for eligible students. Parents were not billed for any fees. Data were collected regarding implementation costs and vaccine cost was calculated using published private sector prices. Reimbursement amounts were compared to costs. RESULTS: Overall, 30% of students (2784 of 9295) received ≥1 influenza vaccine; 39% (1079 of 2784) needed 2 doses and 80% received both. Excluding vaccine costs, implementation costs were $24.69 per vaccination. The percentage of vaccine costs reimbursed was 62% overall (82% from State Child Health Insurance Program (SCHIP), 50% from private insurance). The percentage of implementation costs reimbursed was 19% overall (23% from private, 27% from Medicaid, 29% from SCHIP and 0% among uninsured). Overall, 25% of total costs (implementation plus vaccine) were reimbursed. CONCLUSIONS: A SLIV program resulted in vaccination of nearly one third of elementary students. Reimbursement rates were limited by 1) school restrictions on charging parents fees, 2) low payments for vaccine administration from public payers and 3) high rates of denials from private insurers. Some of these problems might be reduced by provisions in the Affordable Care Act.
Authors: Allison Kempe; Alison W Saville; Christina Albertin; Laura Helmkamp; Xinkai Zhou; Sitaram Vangela; L Miriam Dickinson; Chi-Hong Tseng; Jonathan D Campbell; Melanie Whittington; Dennis Gurfinkel; Heather Roth; Dina Hoefer; Peter Szilagyi Journal: Acad Pediatr Date: 2019-11-05 Impact factor: 3.107
Authors: Byung-Kwang Yoo; Sharon G Humiston; Peter G Szilagyi; Stanley J Schaffer; Christine Long; Maureen Kolasa Journal: BMC Health Serv Res Date: 2015-11-16 Impact factor: 2.655
Authors: Cuc H Tran; Joe Brew; Nicholas Johnson; Kathleen A Ryan; Brittany Martin; Catherine Cornett; Brad Caron; R Paul Duncan; Parker A Small; Paul D Myers; J Glenn Morris Journal: Vaccine Date: 2016-04-25 Impact factor: 3.641